See also this year's filing and all EDGAR filings for this company.
PDF Report 0001636282_2021_Spyre_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001636282, Spyre Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 149,789,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,642,000 |
| 3 | remainder_Assets | 6,187,000 |
| 4 | LiabilitiesCurrent | 16,443,000 |
| 5 | LiabilitiesNoncurrent | 5,343,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 27,896,808 |
| 9 | ResearchAndDevelopmentExpense | 57,497,276 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 750,581 |
| 13 | remainder_ComprehensiveNetIncome | -5,279 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 161,618,000 |
| 1 | Liabilities | 21,786,000 |
| 2 | Expenses | 85,394,084 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 139,832,000 |
| 5 | NetIncome | -84,643,503 |
| 6 | ComprehensiveNetIncome | -84,646,142 |
| 7 | BaseVar | 134,776,972 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.40 |
| 9 | EconomicCapitalRatio | 3.29 |
Edgar->Model Mapping
Feature Distribution
Change over Time
